These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 29654898

  • 1. Improvement of intestinal transport, absorption and anti-diabetic efficacy of berberine by using Gelucire44/14: In vitro, in situ and in vivo studies.
    Sun J, Bao H, Peng Y, Zhang H, Sun Y, Qi J, Zhang H, Gao Y.
    Int J Pharm; 2018 Jun 10; 544(1):46-54. PubMed ID: 29654898
    [Abstract] [Full Text] [Related]

  • 2. Nanoemulsion improves hypoglycemic efficacy of berberine by overcoming its gastrointestinal challenge.
    Xu HY, Liu CS, Huang CL, Chen L, Zheng YR, Huang SH, Long XY.
    Colloids Surf B Biointerfaces; 2019 Sep 01; 181():927-934. PubMed ID: 31382342
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Berberine analogue IMB-Y53 improves glucose-lowering efficacy by averting cellular efflux especially P-glycoprotein efflux.
    Shan YQ, Ren G, Wang YX, Pang J, Zhao ZY, Yao J, You XF, Si SY, Song DQ, Kong WJ, Jiang JD.
    Metabolism; 2013 Mar 01; 62(3):446-56. PubMed ID: 23079743
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Solid dispersion of berberine-phospholipid complex/TPGS 1000/SiO₂: preparation, characterization and in vivo studies.
    Zhang Z, Chen Y, Deng J, Jia X, Zhou J, Lv H.
    Int J Pharm; 2014 Apr 25; 465(1-2):306-16. PubMed ID: 24456672
    [Abstract] [Full Text] [Related]

  • 10. Transforming berberine into its intestine-absorbable form by the gut microbiota.
    Feng R, Shou JW, Zhao ZX, He CY, Ma C, Huang M, Fu J, Tan XS, Li XY, Wen BY, Chen X, Yang XY, Ren G, Lin Y, Chen Y, You XF, Wang Y, Jiang JD.
    Sci Rep; 2015 Jul 15; 5():12155. PubMed ID: 26174047
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Characterization, pharmacokinetics, and hypoglycemic effect of berberine loaded solid lipid nanoparticles.
    Xue M, Yang MX, Zhang W, Li XM, Gao DH, Ou ZM, Li ZP, Liu SH, Li XJ, Yang SY.
    Int J Nanomedicine; 2013 Jul 15; 8():4677-87. PubMed ID: 24353417
    [Abstract] [Full Text] [Related]

  • 13. In silico network pharmacology and in vivo analysis of berberine-related mechanisms against type 2 diabetes mellitus and its complications.
    Di S, Han L, An X, Kong R, Gao Z, Yang Y, Wang X, Zhang P, Ding Q, Wu H, Wang H, Zhao L, Tong X.
    J Ethnopharmacol; 2021 Aug 10; 276():114180. PubMed ID: 33957209
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pharmacokinetic interactions between metformin and berberine in rats: Role of oral administration sequences and microbiota.
    Lyu Y, Zhang Y, Yang M, Lin L, Yang X, Cheung SCK, Shaw PC, Chan PKS, Kong APS, Zuo Z.
    Life Sci; 2019 Oct 15; 235():116818. PubMed ID: 31473193
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.